Skip to main content
H

HANGZHOU BIOTEST BIOTECH CO.,LTD. — Investor Relations & Filings

Ticker · 688767 Shanghai Stock Exchange Manufacturing
Filings indexed 449 across all filing types
Latest filing 2026-04-24 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688767

About HANGZHOU BIOTEST BIOTECH CO.,LTD.

Hangzhou Biotest Biotech Co., Ltd. specializes in the research, development, and manufacturing of rapid diagnostic test kits. The company focuses on in vitro diagnostics through lateral flow immunoassay technology. Its product portfolio includes tests for infectious diseases, drugs of abuse, oncology, cardiac markers, and fertility. Biotest provides solutions for clinical laboratories, hospitals, and point-of-care settings. The company maintains rigorous quality control systems and holds various international certifications to ensure the reliability of its diagnostic tools.

Recent filings

Filing Released Lang Actions
博拓生物关于召开2025年年度股东会的通知
Regulatory Filings
2026-04-24 Chinese
博拓生物关于2025年年度利润分配方案及2026年中期分红规划的公告
Regulatory Filings
2026-04-24 Chinese
2025年度审计报告
Regulatory Filings
2026-04-24 Chinese
博拓生物关于公司募集资金存放、管理与实际使用情况的专项报告
Regulatory Filings
2026-04-24 Chinese
博拓生物2025年年度报告摘要
Regulatory Filings
2026-04-24 Chinese
博拓生物关于部分募投项目调整内部投资结构的公告
Regulatory Filings
2026-04-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.